{
  "page_summary": "This page discusses the importance of capturing prior antineoplastic (anti-cancer) treatments in breast cancer studies, providing data examples of subjects' treatment regimens, medications, settings (such as neoadjuvant, adjuvant, metastatic), and related variable metadata for submission. It emphasizes the relevance of both prior and concurrent therapies for analysis but does not define or describe any clinical endpoints.",
  "endpoint_candidates": []
}